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The physiologic importance of parasympathetic influ-
ence on the sinoatrial and atrioventricular nodes is well
established, but the importance of parasympathetic mod-
ulation of ventricular function remains controversial.
Recognized effects of muscarinic cholinergic stimulation
on ventricular automaticity and ventricular repolari-
zation, the ability of muscarinic cholinergic agonists to
antagonize catecholamine effects in the ventricle and
proposed mechanisms for these effects are described.
Anatomic studies have demonstrated a great abundance
of cholinergic nerve endings in association with the ven-
tricular conductingsystem. Stimulationof the vagusnerve
or addition of muscarinic cholinergic agonists suppresses
ventricular automaticity in most speciesand antagonizes
isoproterenol-induced action potential shortening and
isoproterenol-restored slow response action potentials.
In vivo, interactions between the parasympathetic and
sympathetic nervous systems occur at multiple levels.
The parasympathetic nervous system regulates cardiac func-
tion not only directly, but also by means of parasympathetic
modulation of sympathetic effects on the heart. The im-
portance of parasympathetic influence on the sinoatrial and
atrioventricular (AV) nodes is well established (1-5). Para-
sympathetic effects on ventricular electrical function have
also recently been recognized to be physiologically impor-
tant, and may also influence significantly the pathophys-
iologic milieu responsible for the initiation or termination
of certain ventricular arrhythmias.
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Muscarinic cholinergic agonists inhibit release of nor-
epinephrine from sympathetic nerve terminals, inhibit
catecholamine-stimulated adenylate cyclase activity and
alter cyclic guanosine monophosphate (GMP) and pos-
sibly cyclic adenosine monophosphate (AMP) levels.
Evidence is also presented that, in vivo, parasym-
pathetic effects on ventricular electrical function might
influence the pathophysiologic milieu responsible for ini-
tiation or termination of certain ventricular arrhyth-
mias. Vagal influences appear to be protective against
certain digitalis-induced arrhythmias and protective in
certain experimental acute myocardial infarctions. In
human beings, there appears to be tonic vagal tone in
the ventricle and vagal stimulation terminates certain
types of ventricular tachycardia. The evidence presented
supports a physiologic role of parasympathetic stimu-
lation in altering ventricular electrical function.
The heart is regulated by both limbs of the autonomic
nervous system. In the sinoatrial node, the parasympathetic
nervous system predominates over the sympathetic nervous
system in control of heart rate (3.6). Atrioventricular nodal
function is under balanced influence of the parasympathetic
and sympathetic nervous systems (3). The importance of
resting parasympathetic tone on human ventricular refrac-
toriness has only recently been postulated (7).
Contrary to early histologic studies (8-10) that indicated
an absence of parasympathetic innervation of the mam-
malian ventricle, more recent studies suggest the presence
of parasympathetic nerve fibers distal to the AV node. The
evidence includes histologic demonstration of sparse num-
bers of cholinergic nerve endings in the ventricular myo-
cardium, but a great abundance of cholinergic nerve endings
in ventricular conducting tissue of both canine and human
hearts (11). Histochemical studies have also localized cho-
line acetyl transferase , the enzyme that catalyzes the syn-
thesis of acetylcholine within the ventricle. (12,13) and have
demonstrated the presence of acetylcholine in the ventricular
myocardium (14). In addition to the evidence establishing
the presence of cholinergic nerves in the ventricles, mus-
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carinic cholinergic receptors on myocardial cells have been
demonstrated directly with ligand-binding assays using [3H]
quinuclidinyl benzilate to label the receptors (15,16). These
receptors are located both in the ventricular myocardial cell
and in the prejunctional sites in the sympathetic nerve ter-
minals innervating the myocardium (17),
In this article, we will review evidence that parasym-
pathetic innervation of the mammalian ventricle is phys-
iologically important and has clinical implications in altering
arrhythmogenesis. As background, we will review the in
vitro effects of muscarinic cholinergic stimulation on ven-
tricular electrophysiologic variables, present evidence for a
direct, adrenergic independent vagal effect and proposed
biochemical mechanisms of action of the vagus in the ventricle.
Electrophysiologic Effects of Acetylcholine in
the Mammalian Ventricle
Though early publications noted that physiologically rel-
evant concentrations of acetylcholine exerted no effect on
Purkinje fibers (18) or ventricular muscle transmembrane
action potentials (19), more recent reports demonstrate sig-
nificant effects of acetylcholine on ventricular electrical
function. Evidence from both in vivo and in vitro studies
has accumulated to support the important role of vagal stim-
ulation on electrical function in the ventricle,
The effects of acetylcholine on ventricular chrono-
tropy. These effects have been demonstrated in vivo and
confirmed by in vitro microelectrode studies. Eliakim et al.
(20) demonstrated a negative chronotropic response to vagal
stimulation or infusion of acetylcholine in animals with a
normal conduction system. After complete heart block was
established, vagal stimulation or infusion of acetylcholine
still produced a transient slowing of the idioventricular rate.
Others (21) have reported a significant reduction in ven-
tricular rate as a result of vagal stimulation in adenalectom-
ized dogs after removal of the upper vertebral and stellate
ganglia and section of the bundle of His. Similar results
demonstrating a depressant effect of acetylcholine or vagal
stimulation on idioventricular rates in the intact ventricle
are reported (22,23). Using intracellular recording tech-
niques, Bailey et al. (24) demonstrated in the canine bundle
of His and right bundle branch, when rendered automatic
by anatomic isolation in situ, that acetylcholine produced a
significant negative chronotropic effect. Acetylcholine
produced a depression of diastolic depolarization, and as
automaticity was depressed, conduction in the specialized
conducting system was augmented (Fig. I), Similar obser-
vations have also been made in canine cardiac Purkinje fibers
(17,25).
Effects on ventricular action potential. Early electro-
cardiographic studies suggested an effect of acetylcholine
on ventricular action potential characteristics. Fisch et al.
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Figure 1. Effects of acetylcholine, 2 x 1O-5M, on phase four
depolarization and action potential configuration in the branching
portion of the bundle of His and the right bundle branch. The
sketch (lower right) defines the location of stimulating ( f )and
recording (mel and me-) microelectrodes. Solid lines on sketch
indicate incisions in the conductingsystem. A, Control transmem-
brane action potentials recorded at sites mel and mel. B, Acetyl-
choline, (2 x 1O-5M), at 7 minutes of superfusion produces a
depression of the slope of phase four depolarization and increases
the takeoff potential total amplitudeand overshootof the proximal
cell. C, With washoutof acetylcholine, the actionpotentialsreturn
towardcontrol. Zero potential is markedineachpanel. Calibrations
vertical = 25 mV. horizontal = 0.5 s. (Reprinted from Bailey
JC, et al. [24] by permission of the Amencan Heart Association,
Inc.)
(26) showed that acetylcholine consistently increased T wave
amplitude, independent of changes in extracellular potas-
sium concentration. It was presumed from this observation
that acetylcholine increased the rate of ventricular repolar-
ization. Data from microelectrode experiments suggest the
effects of acetylcholine on ventricular electrical function are
species-dependent. In the dog, acetylcholine produces either
no change (27) or shortens action potential duration (25).
Carmeliet and Ramon (28) reported that in sheep, acetyl-
choline prolongs the action potential, shifts the plateau in
the positive direction, causes hyperpolarization of the max-
imal diastolic potential and increases the rate of diastolic
depolarization. Similar observations were reported by Lip-
sius and Gibbons (29). At lower potassium concentrations
(K + 3.4 or 2.7 mM), the increase in diastolic depolarization
leads to spontaneous all or none depolarization. Voltage
clamp data from sheep demonstrate that these changes in
action potential characteristics produced by acetylcholine
are due to a reduction of the background current mainly
carried by potassium (inward and outward rectifier) and to
a lesser extent by sodium (and probably calcium). The slow
inward current as well as the transient inward current are
reduced in amplitude and slowed in time course by acetyl-
choline. The effects on diastolic depolarization are primarily
due to a shift of the activation curve of the pacemaker current
a few millivolts in the depolarizing direction, without a
change in the rectifier ratio (30,31).
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Ochi and Hino (32) reported that in the guinea pig pap-
illary muscle, superfusion of acetylcholine produces a re-
duction in action potential duration and a reduction in the
plateau of the action potential. In ventricular muscle, re-
polarization may be due to a time-dependent decrease of
inward calcium current (i,.) rather than an increase in out-
ward potassium currents (33,34). Hino and Ochi (35) dem-
onstrated that in guinea pig papillary muscle, acetylcholine
produces a dose-dependent reduction in the amplitude of i.,
and no increase in the outward potassium currents. Thus,
microelectrode studies have demonstrated, in the majority
of mammalian species studied, that acetylcholine alters elec-
trophysiologic variables in the ventricle. In general, ace-
tylcholine depresses ventricular automaticity (except in the
sheep) and produces slight, if any, alteration in action po-
tential duration. In numerous experiments from our labo-
ratory, acetylcholine has been found to produce no change
in action potential duration in guinea pig ventricular or dog
Purkinje fibers, but produces a negative chronotropic effect
in Purkinje fibers of either species.
Figure 2. The effects of acetylcholine on the shortening of action
potential duration effected by isoproterenol. A, A control cardiac
Purkinje fiber action potential. B, Action potential duration short-
ening produced by isoproterenol (l0-7M). C, The addition of
acetylcholine (l0-6M) partially reversed the shortening of action
potential duration effected by isoproterenol. D, Atropine (l0-6M)
attenuated the effects of acetylcholine, resulting in an action po-
tential duration resembling that produced by the superfusion of
isoproterenol alone. Zero potential indicated in each panel. Cali-
brations: horizontal bar = 50 ms; vertical bar = 25 mY. (Re-
printed from Bailey lC, et al. [27] by permission of the American
Heart Association, Inc.)
~-~ ~.-----::.l
Figure 3. The effects of acetylcholine on an isoproterenol-de-
pendent "slow response." A, Control Purkinje fiber action po-
tential in 4 mM potassium. B, Generalized depolarization and loss
of excitability produced by superfusion of Tyrode's solution con-
taining 22 mM potassium. C, Restoration of excitability by the
addition of I0-7M isoproterenol. D, The addition of acetylcholine
(10- OM) abolishes the slow response generated by the addition of
isoproterenol. Zero potential lines and calibrations as in Figure 3.
(Reprinted from Bailey lC, et al. [27] by permission of the Amer-
ican Heart Association, Inc.)
free, high calcium solutions (27), suggesting that the effects
of acetylcholine were specifically antiadrenergic.
Avian versus mammalian heart. The electrophysio-
logic effects of acetylcholine are more marked in the mam-
malian atria than in the mammalian ventricle. Biegon and
Pappano (42) demonstrated in the avian ventricle, inhibition
of calcium-dependent action potentials by cholinergic ag-
onists by two different mechanisms. In embryonic ventri-
cles, acetylcholine had no effect on calcium-dependent ac-
tion potentials evoked in 25 mM potassium in the absence
of isoproterenol. However, in ventricles of this group, ace-
tylcholine or carbamylcholine inhibited action potentials which
Accentuated Effects of Acetylcholine in the
Presence of Simultaneous
Adrenergic Stimulation
Accentuated antagonism. Although acetylcholine is
known to alter ventricular chronotropy, it is generally rec-
ognized that the effects of acetylcholine are greatly enhanced
in the presence of simultaneous sympathetic stimulation (36).
This enhanced response to parasympathetic stimulation in
the presence of simultaneous sympathetic tone has been
termed accentuated antagonism (36).
One of the earliest examples of accentuated antagonism
was described by Rosenblueth and Simeone (37). They noted
that in anesthetized cats, the absolute reduction in heart rate
produced by a given vagal stimulus was greater when the
basal heart rate was increased by tonic sympathetic stimu-
lation. Samaan (38) showed that the cardiac acceleration
produced by strong sympathetic stimulation was over-
powered by weak vagal activity. The accentuated effects of
acetylcholine, or vagal stimulation in the presence of sym-
pathetic stimulation have been confirmed by others (3,39,40).
The ability of acetylcholine to antagonize catecholamine-
induced electrophysiologic effects has been well established
in vitro. Bailey et al. (27) demonstrated that acetylcholine
inhibited isoproterenol-induced action potential shortening
in normally polarized, paced cardiac Purkinje fibers (Fig.
2). Acetylcholine also abolished isoproterenol-induced slow
response action potentials in potassium depolarized canine
cardiac Purkinje fibers (27) (Fig. 3) or guinea pig papillary
muscles (41). Acetylcholine failed to antagonize action po-
tential shortening in canine cardiac Purkinje fibers super-
fused with high calcium Tyrode's solution, or to antagonize
calcium-dependent action potentials generated in sodium-
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wereaugmentedby isoproterenol. Whencalcium-dependent
action potentials were augmentedby increasing the calcium
concentration of the superfusate, acetylcholine did not in-
hibit the action potentials,
In avian ventricles, obtained 5 days after hatching, ace-
tylcholineproduceda direct inhibitionof calcium-dependent
action potentials and continued to inhibit indirectly action
potentials augmented by isoproterenol . These electrophys-
iologic changes paralleled differences in total tissue cyclic
adenosine monophosphate (AMP) observed between em-
bryonicand hatchedavian ventricles (Table I). Whencyclic
AMP levels were increased (ventricles from hatched chicks),
acetylcholine produced a direct adrenergic-independent in-
hibition of calcium-dependent action potentials; however,
whencyclic AMP levels were lower (embryonicventricles),
acetylcholine producedan indirectadrenergic-dependent in-
hibition of calcium-dependent action potentials.
The avian ventricles obtained from hatched animals re-
spond to muscarinic cholinergic stimulation in many re-
spects like the mammalian atria, which have a recognized
direct response to infusionof acetylcholine. The embryonic
avian heart, on the other hand, behaves as many believe the
mammalian ventricle behaves with acetylcholine stimula-
tion, producing only indirect effects when applied in the
presence of simultaneous sympathetic stimulation.
Proposed Mechanisms of Action of
Muscarinic Cholinergic Stimulation
in the Ventricle
Cholinergic inhibition of norepinephrine release from
sympathetic terminals. The interaction between the sym-
pathetic and parasympathetic nervous systems occurs at
multiple levels, including interactions in the central nervous
system, interneurally, the level of the myocardial cell sar-
colemmal membrane and possibly within the myocardial
cells (36,43-45) (Fig. 4). An interneural interaction be-
tweenthe sympatheticand parasympathetic nervoussystems
can be surmised by an acetylcholine-induced reduction in
norepinephrine output from isolated perfused rabbit hearts.
Acetylcholine perfusion produces a dose-dependent reduc-
tion in norepinephrine output and this effect is blocked by
atropine (46). Vagal stimulation producingendogenousace-
tylcholine causes a similar reduction in norepinephrine out-
put in perfused hearts. The mechanism of this presynaptic
effect is unknown. Possibilities include cholinergic inter-
ference with the calcium-dependent excitation-secretion
couplingor muscarinic-inducedhyperpolarization of the ter-
minal membrane.
Cholinergic inhibition of norepinephrine release from
sympathetic nerve terminals cannot be the sole mechanism
responsible for cholinergic attenuation of the cardiac re-
sponse to sympathetic stimulation, Both in isolated cat (47)
and dog (48) hearts, acetylcholine antagonizes the positive
inotropic effects of infused norepinephrine. At the cellular
level, beta-adrenergic agonists are known to increasecyclic
AMP levels (49,50), and enhancement of the slow inward
current (i,,) occurs when cyclic AMP levels are increased
(49,51,52). Several investigators (53,54) havedemonstrated
that muscarinic agonists attenuate beta agonist-induced in-
creases in steady state cyclic AMP levels, However, the
mechanism of this attenuation is not yet entirely clarified,
Myocardial cell receptor-mediated muscarinic cholin-
ergic effect. Several possible intracellular sites of inter-
action between the sympathetic and parasympathetic ner-
vous systems exist. First, muscarinic cholinergic agonists
inhibitboth basal- and epinephrine-stimulatedadenylate cy-
clase activity in preparations of the canine myocardium
(55,56). The specific biochemical and molecular mecha-
nisms by which activation of muscarinic receptors inhibits
adenylate cyclase remain to be elucidated, yet it seemsclear
that muscarinic agonists can diminish tissue cyclic AMP
levels by inhibiting catecholamine stimulation of adenylate
cyclase.
Second, a possible interaction between cyclic guanosine
monophosphate (OMP) and cyclic AMP is postulated, In
cardiac tissues, stimulation of muscarinic cholinergic re-
ceptors results in increased cyclic OMP levels (57,58) . An-
alogs of cyclic OMP mimic the direct effects of muscarinic
Table 1. Effects of Acetylcholine on Basal Cyclic Adenosine Monophosphate and lts Accumulation Induced by Isoproterenol in
Avian Ventricles
Cyclic AMP (pmol/rng wet weight)
Basal
Acetylcholine (I0 - 0M)*t
Isoproterenol (I0 - 0M)*
Isoproterenol +
acetylchollne*
18 Days Embryonic
04 :!: 0 .04 1I8)
0.4 := 0 .05 (4)
0 .7 :!: 008 (5)t
05 :!: 0 Oil (4)
7 Days After Hatching
06 :!: 0 .05 (7)
0.4 :!: 0 .08 (5) t
I 0 :!: 0 .07 (4) t
0.8 :!: 0.03 (3)
"Acetylcholine for 3 minutes by Itself or dunng the last 3 minute, of a 6 mmute exposure to isoproterenol. t Propranolo l (3 x 1O- 7M), present to
antagonize endogenous catecholamine effects, had no significant effect, on cyclic adenosine monophosphate . tp < 0.05 when compared WIth basal
values for the same age. FIgures In parentheses indicate the number of experiments .
(Repnnted from Biegon RL. Pappano AJ . [42] by permission of the Amencan Heart Association, lnc.)
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stimulation are currently being investigated, but their phys-
iologic importance is uncertain.
VAGUS
SY MP c:e-----<
.-.c:t.... .c .....
Figure 4. Schematic diagram depicting the possible sites of in-
teraction between the sympathetic (SYMP) and parasympathetic
(VAGUS) nervous systems. Diagram represents the intracellular
space to the right, sarcolemmal membrane and intramyocardial
sympathetic andparasympathetic fibers totheleft. Parasympathetic
stimuli can: I) inhibit norepinephrine release from sympathetic
nerve terminals; 2) inhibit catecholamine-induced increases in
adenylate cyclase activity; 3) increase cyclic guanosine mono-
phosphate (GMP), which may possibly inhibit actions of cyclic
adenosine monophosphate (AMP); and4) possibly inhibit protein
kinase-mediated phosphorylation of myocardial cell proteins. ATP
= adenosine triphosphate; GTP = guanosine triphosphate.
agonists and decrease sinoatrial node automaticity (59), in-
hibit atrial slow response action potentials (60) and produce
a negative inotropic effecton ventricular myocardium (61,62).
However, elevation of cyclic GMP by nitroprusside, which
does not interact with muscarinic receptors, does not mimic
the inotropic (63,64), electrophysiologic (65,66) or antiad-
renergic (63,67,68) effects of acetylcholine. Additional ar-
guments against a role of cyclic GMP in mediating certain
physiologic effects are the observations that over a range
of concentrations of muscarinic agonist, certain physiologic
effects can be induced without changing cyclic GMP levels
and that physiologic effects are evident before changes in
total intracellular cyclic GMP content. Acetylcholine can
decrease automaticity and shorten action potential duration
in guinea pig atria apparently without any relation to cyclic
GMP levels (65). At present, the role of cyclic GMP in
mediating muscarinic cholinergic effects remains unclear,
with substantial bodies of evidence both supporting and
arguing against an important role for this nucleotide.
Thus in the intact heart. evidence exists both for cholin-
ergic inhibition ofnorepinephrine release from sympathetic
terminals and a myocardial cell receptor-mediated mus-
carinic cholinergic effect. Multiple sites for myocardial cel-
lular effects are postulated. Muscarinic cholinergic agonists
inhibit adenylate cyclase activity and increase cyclic GMP.
Additional intracellular effects of muscarinic cholinergic
treated and control animals (Fig. 5 and 6). The negative
Evidence for a Direct Effect of Acetylcholine
on Ventricular Electrophysiologic Variables
As previously noted, acetylcholine is known to produce
direct adrenergic-independent effects in the mammalian si-
noatrial node tissue, atrial muscle and atrioventricular node
tissue and is known to antagonize catecholamine effects in
the mammalian ventricle. Numerous studies have demon-
strated effects of muscarinic cholinergic stimulation on ven-
tricular electrical function, but the majority of these studies
were not designed specifically to evaluate the possibility
that endogenous norepinephrine release might modify the
effect of the cholinergic agonists. There is a continuous
release of norepinephrine stores from postganglionic sym-
pathetic terminals (69) that is reduced when the pregan-
glionic sympathetic fibers are cut (70). The possibility of
the influence of endogenous norepinephrine in modifying
or accentuating cholinergic effects has been taken into ac-
count in only a few electrophysiologic studies (28,42).
Rardon and Bailey (71) demonstrated that muscarinic
cholinergic stimulation produced a direct (adrenergic-in-
dependent) negative chronotropic response in isolated guinea
pig ventricular strips. The chronotropic response to phy-
sostigmine was similar in reserpine-pretreated, tyramine-
Figure 5. Effects of tyramine (1O- 4M), physostigmine (lO-6M)
and atropine (lO-6M) on transmembrane Purkinje fiber action po-
tentials from a reserpine-pretreated guinea pig. A, Control cardiac
Purkinje fiber action potentials. B, Superfusion oftyramine produced
noincrease inrate. C, Superfusion ofphysostigmine which produced
a negative chronotropic response. D, Atropine attenuated the ef-
fects of physostigmine. Zero potential indicated in each panel.
Calibrations: horizontal bar = 0.4 s; vertical bar = 40 mV on
lower tracing in each panel and 8 mV in the magnified upper
tracing. (Reprinted from Rardon DP, Bailey lC. [71] by permis-
sion of the American Heart Association, Inc.)
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Figure 6. Effects of tyramine (10 5M), physostigmine (10 6M )
and atropine (l0 - 6M) on transmembrane Purkinje fi ber action po-
tentials from a tyramine-treated guinea pig ventricular strip. A,
Control cardiac Purkinje fiber action potentials. B, Superfusion of
tyramine increased the spontaneous rate. C, Simultaneous super-
fusion of tyramine and physostigmine slowed the rate. D, Super-
fusion of atropine attenuated the effects of physostigmine. Zero
potential indicated in each panel. Calibrations as in Figure 5.
(Reprinted from Rardon DP. Bailey Jc. 171] by permission of the
American Heart Association. Inc.)
chronotropic response was not diminished by reserpine pre-
treatment or reserpine pretreatment plus propranolol. nor
was it accentuated during simultaneous treatment with ty-
ramine. Carmeliet and Ramon (28) demonstrated that the
electrophysiologic effects of acetylcholine in sheep cardiac
Purkinje fibers were not antagonized by the simultaneous
treatment of the preparations with propranolol or
phentolamine.
Evidence from these studies supports the hypothesis that
muscarinic agonists are able to produce direct electrophys-
iologic effects because of postjunctional cellular effects in-
dependent of the presence of discernible adrenergic tone.
Effects of Muscarinic Cholinergic Stimulation
in Intact Animals and Human Beings
Data have been presented demonstrating the anatomic
presence of cholinergic innervation of the ventricle. the
effects of muscarinic cholinergic stimulation on ventricular
muscle and cardiac Purkinje fiber action potential charac-
teristics. the ability of muscarinic cholinergic agonists to
antagonize catecholamine effects and the ability of mus-
carinic cholinergic agonists to exert adrenergic-independent
effects in the mammalianventricle. This section will present
data to support the notion that vagal effects alone or in
combination with heightenedadrenergic tone have important
consequences in vivo. and that vagal stimulation may have
an important role in regulating ventricular electrophysio-
logic variables. The vagus nerve may subserve a significant
role in modifying the propensity for certain cardiac arrhyth-
mias.
Role in genesis of arrhythmias. Both limbs of the auto-
nomic nervous system play important roles in the genesis
of arrhythmias. Stimulation of specific sites in the central
nervous system results in arrhythmias that suggest enhanced
parasympathetic discharge. that is, sinus bradycardia, atrial
asystole, atrial flutter and atrial fibrillation (72). Parasym-
pathetic stimulation may induce arrhythmias by depressing
the sinus pacemaker, depressing or blocking AV conduction
or altering the repolarization rate of regions of the myo-
cardium (73). Cholinergic stimulation shortens the atrial
refractory period and is associated with induction and pro-
longation of atrial fibrillation (74-76) . The arrhythmogenic
effects of central nervous system stimulation probably result
from interaction between both the parasympatheticand sym-
pathetic nervous systems. Vagal effects are pronounceddur-
ing periods of heightened sympathetic tone.
Protective effect on ventricular arrhythmias. The in-
fluence of vagal stimulation on the occurrence of ventricular
arrhythmias has been recognized for many years. In 1859,
Einbrodt (77) used an inductorium to provoke ventricular
fibrillation in dogs. He delivered increasing current by ap-
proximating the coils and measured the ventricular fibril-
lation threshold by changing the distance between the coils.
In the control state, ventricular fibrillation was provoked at
a coil distance of 90 ern, During vagal stimulation, the
spacing could be narrowed to 30 ern before ventricular fi-
brillation occurred. Einbrodt concluded like other investi-
gators since then (78-80) that vagal stimulation was pro-
tective against ventricular arrhythmias. Vagomimetic drugs
(81,82) protect against, while vagotomyand vagolytic drugs
(83,84) predispose to ventricular arrhythmias.
Though the influence of vagal stimulation on ventricular
arrhythmias is recognized, the mechanisms of this protective
effect are only poorly understood. Kolman et al. (85) dem-
onstrated a protective effect of vagal stimulation on the
threshold for ventricular fibrillation only during periods of
enhanced sympathetic activity. Similarly, Rabinowitz et al.
(86). using the repetitive extrasystole threshold technique,
demonstrated that methylcholine chloride produced a large
increase in the ventricular fibrillation threshold in anesthe-
tized dogs. Methylcholine infusion was associated with a
decrease in arterial blood pressure and a reflex sinus tachy-
cardia suggesting a high level of sympathetic tone. Beta-
adrenergic blockade induced with propranolol resulted in an
increase in the repetitive extrasystole threshold which was
not increased further by simultaneous administration of
methylcholine. Martins and Zipes (87) demonstrated that in
:x -chloralose anesthetized dogs, vagal stimulation prolonged
the effective refractory period of the left ventricular epi-
cardium. endocardium and left septum to a similar degree.
Sympathetic denervation of the heart reduced this effect and
pretreatment with propranolol eliminated vagal-inducedpro-
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longation of the effective refractory period. These data sug-
gest that the vagal effect on ventricular vulnerability is pri-
marily due to an indirect effect occurring only at heightened
levels of sympathetic tone.
Evidence for both a direct as well as indirect muscarinic
effect is suggested by the work of Amlie and Refsum (88).
They demonstrated in pentobarbital-anesthetized dogs (to
induce a high sympathetic background activity) that vagal
stimulation produced a slight increase in right ventricular
monophasic action potential duration (139 to 147 ms) when
the heart was paced at a fixed rate (cycle length of 350 ms) .
After beta-adrenergic receptor blockade with atenolol (0.5
mg/kg), monophasic action potential duration was increased
but vagal stimulation still produced a further increase in
action potential duration (147 to 152 ms at a cycle length
of 350 ms). They found similar increases in ventricular
functional and effective refractory periods with vagal stim-
ulation before and after beta-adrenergic receptor blockade.
Role in digitalis-induced arrhythmias. Vagal influ-
ences may play an important role in regulation of arrhyth-
mias that occur under various clinical situations. Digitalis
in toxic doses increases the neural activity in cardiac sym-
pathetic and parasympathetic nerves (89-92). Digitalis-in-
duced hyperactivity in cardiac sympathetic nerves can be
depressed by diphenylhydantoin (90), propranolol (89),
clonidine (91) and chlordiazepoxide (93). These drugs result
in a reduction of neural activity and an abolition of digitalis-
induced cardiac arrhythmias. The intact parasympathetic
nervous system appears to be protective against digitalis-
induced arrhythmias. Sectioning of the vagus nerves de-
creases the dose of ouabain, digoxin and acetylstrophan-
thidin needed to produce cardiac arrhythmias (94).
Ventricular arrhythmias in experimental coronary
occlusion and myocardial infarction. As in the case of
digitalis, coronary artery occlusion results in increased neural
activity in cardiac sympathetic and parasympathetic nerves
(90,95) . Sympathetic hyperactivity may occur in an asyn-
chronous manner (96) . Both homogenous sympathetic and
asynchronous sympathetic stimulation may be important in
the generation of early ventricular arrhythmias occurring
after coronary artery occlusion .
Several investigators (97-99) have demonstrated that.
in fact. vagal stimulation is protective during acute myo-
cardial infarction. Kent et al. (98) demonstrated that dis-
parity of ventricular refractory periods decreased as the heart
rate was increased in nonischemic myocardium (but in-
creased in ischemic myocardium) and that vagal stimulation
raised the ventricular fibrillation threshold in dogs . Myers
et al. (99) demonstrated that vagal stimulation and brady-
cardia were associated with a postponement or prevention
of ventricular fibrillation. Others (100-102) have also dem-
onstrated a beneficial effect of vagal stimulation in exper-
imentally induced acute coronary artery occlusion.
Experimental results examining the vagolytic effects of
atropine in the setting of acute myocardial infarction are
inconsistent. Atropine has been shown to be beneficial,
harmful and without effect in this setting. Corr and Gillis
(100) demonstrated that atropine (I mg/kg) increased the
incidence of ventricular fibrillation after anterior myocardial
infarction, whereas no effect was seen after inferior myo-
cardial infarction. LeRoy et al. (103) reported that atropine
(0.2 mg/kg) reduced the incidence of ventricular fibrillation
after circumflex coronary occlusion in both the anesthetized
and conscious dog. Corr and Gillis ( 10 I) concluded that in
experimental animals , a deleterious response to atropine is
encountered when: 1) anterior myocardial infarction is pres-
ent; 2) atropine is administered during the early hours after
ischemia; and 3) the ventricular premature complexes have
short coupling intervals. Bilateral vagotomy increases the
mortality rate and incidence of ventricular fibrillation fol-
lowing left anterior descending artery occlusion in the cat
(100,102) .
These studies suggest that atropine and bilateral vagot-
omy may be detrimental under certain experimental con-
ditions in the setting ofacute myocardial ischemia . In clin-
ical studies, atropine has been demonstrated to be beneficial
in some patients. The therapeutic value of atropine is to
correct bradycardia or heart block, or both, and to relieve
hypotension. This clinical situation occurs primarily in pa-
tients with inferior myocardial infarction, and differs from
those experimental settings previously mentioned where
atropine and bilateral vagotomy result in a detrimental effect.
Mechanisms of protective effect. The mechanisms re-
sponsible for this protective effect of vagal stimulation after
coronary artery ligation are not well defined. Arrhythmias
occurring during the early interval after myocardial ischemia
may be due to a reentrant mechanism, whereas arrhythmias
occurring several hours after myocardial ischemia are pri-
marily the result of increased automaticity (103-105). Ac-
cording to Wit and Bigger (105), "transmembrane action
potentials have not been recorded from ischemic myocar-
dium in the in situ heart during the early phase of ventricular
arrhythmias, so that the actual cellular electrical events which
accompany these arrhythmias are a matter of conjecture."
Though the cellular electrical events responsible for these
arrhythmias are unknown, microelectrode studies suggest
possible theoretical benefits of vagal stimulation . In vitro
microelectrode studies (17,24) have demonstrated that ace-
tylcholine decreases phase four depolarization, increases
maximal diastolic potential and improves conduction ve-
locity secondary to an increase in the velocity of the up-
stroke , particularly if the response is premature (17). These
effects of muscarinic cholinergic stimulation are most likely
due to increased potassium conductance and would be ex-
pected to improve conduction velocity and possibly elimi-
nate a slowed reentrant pathway . Additionally, acetylcho-
line suppresses slow response electrical activity and
antagonizes catecholamine-induced effects in the ventricle.
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These effects alone or in combination may play a role in
the protective effect of vagal stimulation during acute myo-
cardial ischemia.
Clinical implications. The importance of vagal effects
in the human ventricle has only recently been proposed by
Prystowsky et al. (7), who studied the effects of autonomic
blockade on ventricular refractoriness in human beings. They
demonstrated that elimination of tonic muscarinic cholin-
ergic activity shortens ventricular refractoriness determined
in the right ventricular apex in humans. Their data suggested
a lack of significant background sympathetic tone as well.
Because the effect of atropine occurred during beta-adren-
ergic blockade, it appears that muscarinic cholinergic ac-
tivity did not require background sympathetic tone to exert
its effect on the human right ventricle, but directly prolonged
ventricular refractoriness.
Waxman et al. (106) reported termination of ventricular
tachycardia in 5 patients, and in a later report (107) de-
scribed termination of ventricular tachycardias in an addi-
tional 12 of 13 patients by infusion of phenylephrine. Phen-
ylephrine produces hypertension and reflexly produces an
increase in vagal tone. In 4 of these 12 patients studied in
greater detail, edrophonium (15 to 20 mg, intravenously)
decreased, whereas atropine (2.4 mg, intravenously) in-
creased the dose of phenylephrine required to abolish ven-
tricular tachycardia. Carotid sinus massage after pretreat-
ment with edrophonium in high doses terminated ventricular
tachycardia in these four patients. These data suggest that
high levels of parasympathetic tone terminated ventricular
tachycardia in these selected patients.
Although the precise electrophysiologic mechanisms re-
sponsible for specific instances of ventricular tachycardia in
human beings cannot be elucidated, ample data from animal
and human experiments indicate that, under appropriate cir-
cumstances, vagal stimulation or cholinergic agonists exert
significant effects on ventricular excitability, refractoriness,
automaticity and conduction speed. These direct and indirect
electrophysiologic effects of the vagus nerve may alter sub-
stantially the propensity for the development or termination
of ventricular arrhythmias.
We acknowledge, with gratitude, the expert technical assistance of David
Mendel and the secretanal aid of Carmen Mason.
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